| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 21 |
| 1 | DEXAMETHASONE | 15 |
| 2 | DEXAMETHASONE 1.5 MG | 15 |
| 3 | DAPAGLIFLOZIN | 14 |
| 4 | CISPLATIN | 13 |
| 5 | POTASSIUM CHLORIDE | 13 |
| 6 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 13 |
| 7 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 13 |
| 8 | FLUOROURACIL | 12 |
| 9 | FLUOROURACIL CREAM, 0.5% | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 1 | MANNITOL | 12 | 0.0024 |
| 2 | TALAZOPARIB | 3 | 0.0016 |
| 3 | FOSAPREPITANT DIMEGLUMINE | 12 | 0.0009 |
| 4 | VERTEPORFIN FOR INJECTION | 1 | 0.0007 |
| 5 | TIGECYCLINE | 4 | 0.0006 |
| 6 | MAGNESIUM SULFATE HEPTAHYDRATE | 7 | 0.0005 |
| 7 | ETOMIDATE INJECTION | 1 | 0.0005 |
| 8 | MIDODRINE HYDROCHLORIDE | 2 | 0.0004 |
| 9 | ETOMIDATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 21 |
| 1 | Loop Diuretic [EPC] | 21 |
| 2 | Platinum-based Drug [EPC] | 20 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 16 |
| 4 | Osmotic Laxative [EPC] | 15 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 6 | Potassium Salt [EPC] | 13 |
| 7 | Osmotic Diuretic [EPC] | 12 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 9 |
| 9 | Alkylating Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 12 | 0.0023 |
| 1 | Tetracycline-class Antibacterial [EPC] | 4 | 0.0005 |
| 2 | Lipopeptide Antibacterial [EPC] | 4 | 0.0004 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Photoenhancer [EPC] | 1 | 0.0003 |
| 5 | Oxazolidinone Antibacterial [EPC] | 6 | 0.0002 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 16 | 0.0001 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |